CareDx Cash Flow Statement
NASDAQ: CDNAHealthcareDiagnostics & ResearchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CareDx free cash flow
In fiscal 2025, CareDx generated $42.0 million of operating cash flow. That left free cash flow of $42.0 million, a free-cash-flow margin of 11.1% of revenue. Free cash flow was up 10.5% from the prior year's $38.0 million.
CareDx returned $87.8 million to shareholders through share repurchases, equal to 209% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
CareDx cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -21.35M | 52.55M | -190.28M | -76.61M | -30.66M | -18.71M | -21.97M | -46.78M | -55.56M | -39.76M |
| Net Income growth (YoY) | -140.64% | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 15.02M | 14.19M | 14.39M | 11.60M | 8.80M | 7.01M | 5.52M | 4.21M | 3.73M | 2.92M |
| Stock-Based Compensation | 34.86M | 66.41M | 49.09M | 46.55M | 36.08M | 23.40M | 22.42M | 7.14M | 1.74M | 2.00M |
| Change in Working Capital | 18.37M | -19.87M | 18.97M | -11.57M | -29.55M | -9.21M | -12.59M | -3.81M | 1.21M | 919.00K |
| Operating Cash Flow | 42.03M | 38.05M | -18.39M | -25.24M | -19.29M | 33.43M | -2.77M | -4.01M | -14.31M | -16.52M |
| Capital Expenditures | — | — | — | — | — | — | — | -2.04M | -186.00K | -549.00K |
| Investing Cash Flow | 2.16M | -483.00K | 40.45M | -228.50M | 47.71M | -100.39M | -22.58M | -7.93M | -6.11M | -21.12M |
| Share Repurchases | -87.77M | -522.00K | -27.54M | -642.00K | 0 | 0 | — | — | — | — |
| Debt Issued | — | — | — | — | — | 0 | 0 | 14.28M | 24.00M | 0 |
| Debt Repaid | — | — | — | — | — | -183.00K | -172.00K | -28.09M | -14.36M | -3.94M |
| Financing Cash Flow | -93.39M | -5.61M | -29.61M | -4.54M | 185.64M | 163.15M | -132.00K | 50.27M | 29.38M | 24.93M |
| Net Change in Cash | -49.29M | 32.49M | -7.66M | -258.25M | 213.76M | 96.46M | -26.33M | 38.33M | 9.07M | -12.63M |
| Free Cash Flow | 42.03M | 38.05M | -18.39M | -25.24M | -19.29M | 33.43M | -2.77M | -6.04M | -14.49M | -17.07M |
This table shows 10 annual periods of CareDx's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CDNA's reporting calendar. What is a cash flow statement?